„Focusing on IL-6/STAT3 Pathway shows the approach of anti-IL-6 antibody (tocilizumab) in the treatment of multiple hydrocephalus“. Current Opinion, Bd. 1, Nr. 01, Dezember 2021, S. 15-19, https://currentopinion.be/index.php/co/article/view/14.